Description
BPC-157 + TB-500 is a two-peptide research blend in one vial: BPC-157 10 mg and TB-500 (thymosin beta-4) 10 mg, 20 mg in total. The pair is one of the most common combinations in preclinical tissue-repair research, joining BPC-157’s angiogenesis and nitric-oxide literature with thymosin beta-4’s actin and cell-migration biology.
BPC-157 + TB-500 Research Details
The blend lets researchers study BPC-157 and thymosin beta-4 together in the same model: BPC-157 for angiogenesis, VEGF and nitric-oxide signaling, and thymosin beta-4 for G-actin binding, cell migration and tissue remodeling. Each component is also sold on its own for single-peptide controls.
Independent lab report not yet posted for this product (tested lots are listed on our Lab Results page)
BPC-157 10 mg · TB-500 (thymosin β4) 10 mg
Lyophilized powder
Laboratory research only
Research Background
Key OneBio research contexts include combined tissue-repair models, wound-model studies, angiogenesis assays, cell-migration research and component-comparison experiments.
Specifications
| Compound | BPC-157 + TB-500 |
| Vial Size | 20 mg (blend) |
| CAS Number | Blend (see components) |
| Molecular Formula | Blend |
| Molecular Weight | Blend |
| Identifier | BPC-157 137525-51-0 · TB-500 (thymosin β4) 77591-33-4 |
| Storage | -4°F long-term; 35-46°F short-term refrigerated; keep sealed, dry and away from light |
Quality Verification
Where an independent third-party lab report is available for a lot, it is posted on our Lab Results page and matched to the lot number on the vial. Each report covers only the lot that was tested. Contact us with your lot number to ask about documentation for your vial.
Handling
Handle only in a qualified laboratory under your institution’s validated protocols. Keep cold-chain handling and avoid repeated freeze-thaw cycles.

Reviews
There are no reviews yet.